Craig Hopkinson Reflects on Alkermes' Approach to New Target Ideation

Identifying potential new targets for research and development is a challenging task facing our industry. Recently, our Chief Medical Officer, Dr. Craig Hopkinson, shared his perspective on Alkermes' unique approach to new target ideation with Pharma Tech Outlook. In this article, he outlines how our strategy supports our efforts to develop potential new medicines for people living with complex psychiatric and neurological disorders. 
Read Craig's article